Cash & equivalents increased 30.2%
Cash & equivalents changed +30.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +30.2% from the comparable as-filed period.
Gross profit changed +35.3% from the comparable as-filed period.
Inventory changed -10.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +29.2% from the comparable as-filed period.
Operating income changed +69.6% from the comparable as-filed period.
Operating margin changed +2115 basis points from the comparable as-filed period.
Revenue changed +31.7% from the comparable as-filed period.
Gross margin changed +188 basis points from the comparable as-filed period.
Selling, general & administrative changed +6.2% from the comparable as-filed period.
Research & development changed -2.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.